|  | Treatment groups | |
---|---|---|---|
CTCAE Category | Name adverse event | Group A n = 19 | Group B n = 18 |
Auditory/Ear | Otitis, middle ear | 1 (0/1/0) | 0 |
Blood/Bone marrow | Anemia - hemoglobin | 1 (1/0/0) | 0 |
 | Leukopenia | 1 (0/1/0) | 0 |
Cardiac arrhythmia | Palpitations | 0 | 2 (2/0/0) |
Constitutional symptoms | Fatique | 2 (0/1/1) | 1 (0/1/0) |
 | Insomnia | 1 (0/0/1) | 0 |
Dermatology/Skin | Hair loss - scalp | 1 (1/0/0) | 0 |
 | Rash | 1 (0/1/0) | 1 (0/1/0) |
Gastrointestinal | Constipation | 2 (2/0/0) | 2 (2/0/0) |
 | Diarrhea | 2 (1/1/0) | 2 (2/0/0) |
 | Heartburn/dyspepsia/nausea | 4 (1/3/0) | 2 (1/1/0) |
 | Ulcera - oral | 0 | 1 (1/0/0) |
 | Ulcera - ileum/colon/rectum | 1 (1/0/0) | 0 |
Hepatobiliary/Pancreas | Pancreas irritation* | 0 | 1 (0/1/0) |
Infection | Infection - gastroenteritis | 1 (0/1/0) | 2 (0/2/0) |
 | Infection - dental-tooth | 1 (0/1/0) | 1 (0/1/0) |
 | Infection - skin | 1 (0/1/0) | 1 (0/1/0) |
Lymphatics | Edema - lower limbs | 2 (1/1/0) | 0 |
Metabolic/Laboratory | Elevated AST, GGT | 1 (1/0/0) | 1 (1/0/0) |
 | Hypokalemia | 1 (0/0/1) | 0 |
Neurology | Dizzyness | 1 (1/0/0) | 0 |
 | Mood alteration - depression | 1 (0/0/1) | 0 |
 | Neuropathy - carpal tunnel syndrome | 1 (0/1/0) | 0 |
Pain | Abdominal | 1 (0/0/1) | 0 |
 | Anal/perianal | 4 (0/4/0) | 1 (0/1/0) |
 | Joint | 0 | 1 (0/1/0) |
 | Chest/thorax | 0 | 1 (0/1/0) |
Pulmonary/Upper respiratory | Dyspnea | 0 | 2 (0/2/0) |
 | Nasal cavity/paranasal sinus reaction | 0 | 2 (0/2/0) |
Renal/Genitourinary | Lower urinary tract symptoms - prostatism | 1 (0/1/0) | 0 |
Secondary malignancy | Secondary malignancy - basalioma - nose | 1 (0/0/1) | 0 |
 | Total n of reported AE | 34 (10/18/6)** | 24 (9/15/0)** |
 | Patients reporting ≥1 AE (n, %) | 16 (84.2%) | 14 (77.8%) |